SCHEMBL23716447

SCHEMBL23716447

N#CCN(C(=O)c1ccccc1)c1cccc(C(=O)Nc2c(Cl)cc(C(F)(C(F)(F)F)C(F)(F)F)cc2Cl)c1F

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 2/20 0.36
DHODH Q02127 2/20 0.33
POLQ O75417 1/20 0.33
MRGPRX4 Q96LA9 2/20 0.33
ABCB1 P08183 1/20 0.33
P2RX1 P51575 1/20 0.33
P2RX4 Q99571 1/20 0.33
P2RX7 Q99572 1/20 0.33
TMPRSS4 Q9NRS4 1/20 0.33
KCNK3 O14649 1/20 0.33
KCNK9 Q9NPC2 1/20 0.33
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.32
MLYCD O95822 1/20 0.32
TRPV1 Q8NER1 1/20 0.32
RXFP1 Q9HBX9 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21563800 0.94 GPBAR1 (0.34) GPBAR1DHODHPOLQMRGPRX4ABCB1
SCHEMBL23716797 0.90 GPBAR1 (0.35) GPBAR1DHODHPOLQKCNK3KCNK9
SCHEMBL30266971 0.90 GPBAR1 (0.35) GPBAR1DHODHPOLQKCNK3KCNK9
SCHEMBL21563473 0.86 GPBAR1 (0.38) GPBAR1DHODHPOLQP2RX1KCNK3
SCHEMBL23716450 0.86 GPBAR1 (0.33) GPBAR1DHODHPOLQMLYCDRXFP1
SCHEMBL23716778 0.86 POLQ (0.38) GPBAR1POLQKCNK3KCNK9LMNA
SCHEMBL30266870 0.85 NPC1 (0.40) KCNK3KCNK9LMNAPOLBRXFP1
SCHEMBL1766938 0.83 GAA (0.39) GPBAR1DHODHABCB1KCNK3KCNK9
SCHEMBL23716929 0.83 SMN1; SMN2 (0.36) GPBAR1POLQP2RX1P2RX7LMNA
SCHEMBL30266722 0.83 POLQ (0.42) GPBAR1POLQKCNK3KCNK9RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238126-A1 Benzamide Compound and Use Thereof METISA BIOTECHNOLOGY CO.,LTD. (CN) 2021-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238126-A1 Benzamide Compound and Use Thereof TMBIM6, BCHE, DDT GPBAR1 1655/4885DHODH 260/4885POLQ 4771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.